Book Navigation

We are sorry, but signing in with LinkedIn is not possible at this time.


Günter Ollenschläger, MD, PharmD, PhD, FRCP Edin, FACP

Guenter Ollenschlaeger was Director of the German Agency for Quality in Medicine, Berlin, from 1995 until March 2014

Chairman of the G-I-N Founding Committee 2002/2003; Chairman of the G-I-N Board of Trustees 2003/2005; Member of the G-I-N Board of Trustees from 2007/2008 until 2011/2012; G-I-N Treasurer 2005/2007 and 2008/2010; Honorary Patron of the Guidelines International Network (appointed 2005)

Guenter Ollenschlaeger October 2008Guenter Ollenschlaeger was Director of the German Agency for Quality in Medicine, Berlin (Joint Institution of the German Medical Association and the National Association of Statutory Health Insurance Physicians) since its foundation in 1995 until March 2014.  In this capacity lead the development and establishment of  several nationwide healthcare quality programmes in Germany:  National Guideline Clearinghouse (1997), National Clearinghouse for Patient Information (1999), German Network for Evidence Based Medicine (2000), and National Programme for Disease Management Guidelines (2002). A trained pharmacist and general internist Dr. Ollenschlaeger did research work in the field of biopharmacy and of clinical nutrition. He worked as a research pharmacist until 1980, and practised internal medicine until 1990. He has been Associate Professor of Internal Medicine at the University of Cologne since 1995. From 1990 until 1995 he headed the Department of Continuing Medical Education and Health Promotion of the German Medical Association. From 2001-2003 he acted as director of the German Association for Quality in Heath Care.

Dr. Ollenschlaeger received his Pharm.D. from the University of Muenster/Westfalia, and his M.D. from the University of Giessen. He earned a Ph.D. in general internal medicine from the University of Cologne, and was elected as a Fellow of the Royal College of Physicians of Edinburgh in 2002.

He has been serving as Member of the Board of  Trustees, German Network for Evidence-based Medicine since its foundation in 2000. In November 2002 he became Founding Member the Guidelines International Network, and was elected as the first Chairman of G-I-N. Other relevant activities: German representative in the Council of Europe Expert Group on Methodology of Clinical Practice Guidelines (1999-2000), member of the AGREE Collaboration (1999-2005), and of the European Research Network in Quality Management in Healthcare (ENQual); WHO-Euro Consultant in guidelines development and implementation.

Guenter Ollenschlaeger is Editor-in-Chief of the German Journal for Evidence and Quality in Healthcare, and of the German edition of Clinical Evidence.

Vision for G-I-N over the next 5 years

8 years have passed since the foundation of G-I-N, and – looking back as Founding Chair 2002-2005, and then G-I-N Treasurer – I think these 8 years have been a success story: In 2010, the network has members on all continents: from a more Eurocentric organisation in 2002, it has been developed into a global network. With its website – including one of the largest guideline databases worldwide – and its excellent annual congresses, G-I-N offers unique possibilities to advance the science and practice of evidence based guidance development and implementation.

With 91 organisational members and 70 individual members along with 4 partners G-I-N has now reached a relatively stable position. Trustees and Committee Members have been prioritising the Network’s activities and deliveries according to the AGMs decisions and to the regular member surveys, with increasing output especially during the last 2 years. And last but not least the Network has a brilliant, hard working and reliable staff.

In the coming years I would like to focus my contribution to G-I-N on the following key areas:

  • consolidating the Network, by increasing the membership, and raising funding from not-for-profit-resources.
  • building strong partnerships with other global players on the field of quality development, healthcare management, and knowledge management in healthcare
  • broaden the Network’s core activities
    • to the different formats and contents of evidence based guidance for healthcare providers, patients and the whole public (e.g. electronic decision support systems and other knowledge management tools
    • to address questions of equity, gender, migration in the guideline world
    • to the science and practice of guideline-based quality indicators
  • expanding G-I-N’s portfolio of services, such as regional meetings, training services, electronic communication via our website, and open access to G-I-N resources
  • attracting guideline groups especially from non English speaking countries and supporting those groups


Page last updated: Feb 13, 2020
Back to top